- Development and prognosis of hepatocellular carcinoma in patients with diabetes
-
Nakatsuka T, Tateishi R
- KMID: 2538200
- Clin Mol Hepatol.
- 2023 Jan;29(1):51-64.
- doi: 10.3350/cmh.2022.0095
The incidence of diabetes mellitus and hepatocellular carcinoma (HCC) has been increasing worldwide during the last few decades, in the context of an increasing prevalence of obesity and non-alcoholic fatty... -
- CITED
-
- Close
- SHARE
-
- Close
- Gadoxetate-Enhanced MRI as a Diagnostic Tool in the Management of Hepatocellular Carcinoma: Report from a 2020 Asia-Pacific Multidisciplinary Expert Meeting
-
Tan CH, Chou Sc, Inmutto N, Ma K, Sheng R, Shi Y, Zhou Z, Yamada A, Tateishi R
- KMID: 2530756
- Korean J Radiol.
- 2022 Jul;23(7):697-719.
- doi: 10.3348/kjr.2021.0593
Gadoxetate magnetic resonance imaging (MRI) is widely used in clinical practice for liver imaging. For optimal use, we must understand both its advantages and limitations. This article is the outcome... -
- CITED
-
- Close
- SHARE
-
- Close
